Supplementary Data 8 from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk

Authors :: Julia Y. Ljubimova
Keith L. Black
Alexander V. Ljubimov
Eggehard Holler
Manuel L. Penichet
Tracy R. Daniels-Wells
Lai S. Leoh
Yongmei L. Chen
Alexander V. Lyubimov
Vida Falahatian
Arthur Rekechenetskiy
Zachary B. Grodzinski
Jethro Hu
Jeremy D. Rudnick
Chirag G. Patil
Serguei I. Bannykh
Adam N. Mamelak
Debiao Li
Shawn Wagner
Ekaterina S. Shatalova
Vladimir A. Ljubimov
Frank B. Furnari
Webster K. Cavenee
Alexandra Chesnokova
Hui Ding
Dmytro Klymyshyn
Anna Galstyan
Rameshwar Patil
Tao Sun
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Figure S10. Expression of Notch-1 and its ligand Jagged1 is significantly decreased in patient-derived glioblastoma cell lines with laminin-411 disruption by CRISPR/Cas9

Tools